<DOC>
	<DOC>NCT01039623</DOC>
	<brief_summary>Healthy volunteers will be vaccinated against H1N1 pandemic influenza. One group will receive the adjuvant vaccine while the other group will get intradermal antigen, without the adjuvant. The antibody production will be compared.</brief_summary>
	<brief_title>Assessment of Safety and Immunogenicity of Intradermal Unadjuvanted Portion of Pandemrix® Via a Microneedle Device With Intramuscular Adjuvanted Pandemrix® as Reference</brief_title>
	<detailed_description>Healthy volunteers will be vaccinated against H1N1 pandemic influenza. One group will receive the adjuvant vaccine while the other group will get intradermal antigen, without the adjuvant. The antibody production will be compared.</detailed_description>
	<criteria>Age: 1864 Both genders Healthy Under 18 or above 64 Not healthy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>Healthy volunteers</keyword>
</DOC>